Counterpoint Mutual Funds LLC Sells 60,154 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Counterpoint Mutual Funds LLC trimmed its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 43.3% during the fourth quarter, Holdings Channel reports. The firm owned 78,668 shares of the pharmacy operator’s stock after selling 60,154 shares during the quarter. Counterpoint Mutual Funds LLC’s holdings in Walgreens Boots Alliance were worth $734,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of the company. State Street Corp raised its stake in Walgreens Boots Alliance by 18.0% in the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock valued at $385,258,000 after buying an additional 6,569,223 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Walgreens Boots Alliance by 43.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 10,969,188 shares of the pharmacy operator’s stock valued at $98,284,000 after acquiring an additional 3,329,857 shares during the period. Two Sigma Advisers LP acquired a new stake in Walgreens Boots Alliance during the 3rd quarter valued at $24,226,000. Amundi boosted its position in Walgreens Boots Alliance by 70.3% during the fourth quarter. Amundi now owns 4,455,720 shares of the pharmacy operator’s stock worth $41,082,000 after purchasing an additional 1,839,045 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in shares of Walgreens Boots Alliance during the 4th quarter worth about $9,685,000. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

WBA has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating and lowered their price objective for the stock from $11.00 to $9.00 in a research report on Friday, February 28th. Evercore ISI boosted their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a report on Monday, January 13th. Truist Financial cut their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Royal Bank of Canada upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 15th. Finally, Bank of America lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $11.54.

Walgreens Boots Alliance Price Performance

Walgreens Boots Alliance stock opened at $11.23 on Monday. The stock’s 50 day moving average price is $10.83 and its two-hundred day moving average price is $9.76. The stock has a market capitalization of $9.70 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The firm had revenue of $39.50 billion during the quarter, compared to analysts’ expectations of $37.40 billion. During the same period last year, the company earned $0.66 earnings per share. The business’s revenue was up 7.6% on a year-over-year basis. On average, equities analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.